As of 2025-04-28, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.05 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 CAD, the upside of Revive Therapeutics Ltd is -310.82%.
Based on its market price of 0.03 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 310.82%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.05 - -0.05 | -0.05 | -310.82% |
| P/E | 0.03 - 0.03 | 0.03 | 1.2% |
| DDM - Stable | (0.14) - 5.33 | 2.59 | 10278.8% |
| DDM - Multi | (0.00) - 0.07 | (0.01) | -120.6% |
| Market Cap (mil) | 12.56 |
| Beta | 4.19 |
| Outstanding shares (mil) | 502.28 |
| Enterprise Value (mil) | 12.50 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.47% |
| Cost of Debt | 5.00% |
| WACC | 6.46% |